Blaslov, K. (2017). EMPA-REG versus canagliflozin cardiovascular assessment study OUTCOME: A class effect after all? VBZ.
Chicago Style (17th ed.) CitationBlaslov, Kristina. EMPA-REG Versus Canagliflozin Cardiovascular Assessment Study OUTCOME: A Class Effect After All? VBZ, 2017.
MLA (8th ed.) CitationBlaslov, Kristina. EMPA-REG Versus Canagliflozin Cardiovascular Assessment Study OUTCOME: A Class Effect After All? VBZ, 2017.
Warning: These citations may not always be 100% accurate.